Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
73.25
+0.25 (0.34%)
At close: Sep 18, 2025, 4:00 PM EDT
73.70
+0.45 (0.61%)
After-hours: Sep 18, 2025, 6:52 PM EDT
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $2.41 billion as of September 18, 2025. Its market cap has increased by 62.36% in one year.
Market Cap
2.41B
Enterprise Value
2.26B
1-Year Change
62.36%
Ranking
Category
Stock Price
$73.25
Market Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $2.41B, an increase of 1,563.56%. That is a compound annual growth rate of 129.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2025 | 2.41B | 23.43% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
| Apr 29, 2022 | 144.57M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.40B |
| Johnson & Johnson | 426.76B |
| AbbVie | 390.07B |
| UnitedHealth Group | 309.39B |
| Novo Nordisk | 260.64B |
| AstraZeneca | 241.43B |
| Novartis AG | 237.64B |
| Abbott Laboratories | 233.52B |